[{"orgOrder":0,"company":"AbbVie Inc","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Enzyme","year":"2022","type":"Inapplicable","leadProduct":"Pancrelipase","moa":"Fatty acids | Starch | Polypeptides","graph1":"Endocrinology","graph2":"Approved FDF","graph3":"AbbVie Inc","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Oral Capsule","sponsorNew":"AbbVie Inc \/ Inapplicable","highestDevelopmentStatusID":"15","companyTruncated":"AbbVie Inc \/ Inapplicable"},{"orgOrder":0,"company":"AbbVie Inc","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Genetic Disease","country":"U.S.A","productType":"Enzyme","year":"2021","type":"Inapplicable","leadProduct":"Pancrelipase","moa":"Fatty acids | Starch | Polypeptides","graph1":"Genetic Disease","graph2":"Phase IV","graph3":"AbbVie Inc","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Genetic Disease","amount2New":0,"dosageForm":"Oral Capsule, Delayed Release","sponsorNew":"AbbVie Inc \/ Inapplicable","highestDevelopmentStatusID":"11","companyTruncated":"AbbVie Inc \/ Inapplicable"},{"orgOrder":0,"company":"AbbVie Inc","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Enzyme","year":"2020","type":"Inapplicable","leadProduct":"Pancrelipase","moa":"Fatty acids | Starch | Polypeptides","graph1":"Endocrinology","graph2":"Approved FDF","graph3":"AbbVie Inc","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Oral Capsule","sponsorNew":"AbbVie Inc \/ Inapplicable","highestDevelopmentStatusID":"15","companyTruncated":"AbbVie Inc \/ Inapplicable"},{"orgOrder":0,"company":"Ohio State University","sponsor":"The University of Pittsburgh School of Medicine | University of Illinois, Chicago | University of Southern California | New York University | AbbVie Inc","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Enzyme","year":"2024","type":"Inapplicable","leadProduct":"Pancrelipase","moa":"Fatty acids | Starch | Polypeptides","graph1":"Endocrinology","graph2":"Phase IV","graph3":"Ohio State University","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Oral Capsule","sponsorNew":"Ohio State University \/ The University of Pittsburgh School of Medicine | University of Illinois, Chicago | University of Southern California | New York University | AbbVie Inc","highestDevelopmentStatusID":"11","companyTruncated":"Ohio State University \/ The University of Pittsburgh School of Medicine | University of Illinois, Chicago | University of Southern California | New York University | AbbVie Inc"}]

Find Clinical Drug Pipeline Developments & Deals for Pancrelipase

Pancrelipase
Drugs in Dev.
Full Screen View

Weekly News Recap
#Phispers

Stock Recap
#PipelineProspector

cayman pipeline prospector

Contact Supplier

Access all COS suppliers
Check all USDMF suppliers

Contact Us
PharmaScopic.com

Pancrelipase

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

9 API Suppliers, 2 USDMF, 2 CEP/COS, 5 NDC API, 1 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

20 Drugs in Development

20 Drugs in Development

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 9 News #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 19 Annual Reports

MARKET PLACE

1 APIs

1 APIs

Xls

Filters

×

filter

Company Name

filter

Year

filter

DEALS // DEV.

filter

Country

filter

Sponsor

filter

Therapeutic Area

filter

Study Phase

filter

Deal Type

filter

Product Type

filter

Dosage Form

filter

Lead Product

filter

Target

All Developments

Therapeutic Area by Lead Product

Study Phase by Lead Product

Company by Lead Product

Top Deals by Deal Size (USD bn)

Reset All

01

AbbVie Inc

U.S.A

Peptide Process CMC

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Lead Product(s) : Pancrelipase

Therapeutic Area : Endocrinology

Study Phase : Approved FDF

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

AbbVie to Present Data from Extensive Portfolio at American College of Gastroenterology Annual Scientific Meet...

Details : CREON (pancrelipase) is prescription medicine used to treat people who cannot digest food normally because their pancreas does not make enough enzymes due to cystic fibrosis, swelling of pancreas that lasts a long time, removal of some or all of pancreas...

Product Name : Creon

Product Type : Enzyme

Upfront Cash : Inapplicable

October 24, 2022

Lead Product(s) : Pancrelipase

Therapeutic Area : Endocrinology

Highest Development Status : Approved FDF

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Abbvie Company Banner

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

02

AbbVie Inc

U.S.A

Peptide Process CMC

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Lead Product(s) : Pancrelipase

Therapeutic Area : Genetic Disease

Study Phase : Phase IV

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or ...

Details : Undisclosed

Product Name : Undisclosed

Product Type : Enzyme

Upfront Cash : Inapplicable

October 06, 2021

Lead Product(s) : Pancrelipase

Therapeutic Area : Genetic Disease

Highest Development Status : Phase IV

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Abbvie Company Banner

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

03

AbbVie Inc

U.S.A

Peptide Process CMC

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Lead Product(s) : Pancrelipase

Therapeutic Area : Endocrinology

Study Phase : Phase IV

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due T...

Details : Undisclosed

Product Name : Undisclosed

Product Type : Enzyme

Upfront Cash : Inapplicable

March 19, 2020

Lead Product(s) : Pancrelipase

Therapeutic Area : Endocrinology

Highest Development Status : Phase IV

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Abbvie Company Banner

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

04

AbbVie Inc

U.S.A

Peptide Process CMC

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Lead Product(s) : Pancrelipase

Therapeutic Area : Genetic Disease

Study Phase : Phase IV

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

A Study to Compare US Marketed Creon Manufactured With a Modernized Process at an Alternate Manufacturing Site...

Details : Undisclosed

Product Name : Undisclosed

Product Type : Enzyme

Upfront Cash : Inapplicable

April 23, 2019

Lead Product(s) : Pancrelipase

Therapeutic Area : Genetic Disease

Highest Development Status : Phase IV

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Abbvie Company Banner

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

05

AbbVie Inc

U.S.A

Peptide Process CMC

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Lead Product(s) : Pancrelipase

Therapeutic Area : Endocrinology

Study Phase : Phase IV

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Panc...

Details : Undisclosed

Product Name : Undisclosed

Product Type : Enzyme

Upfront Cash : Inapplicable

March 01, 2019

Lead Product(s) : Pancrelipase

Therapeutic Area : Endocrinology

Highest Development Status : Phase IV

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Abbvie Company Banner

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

06

Ohio State University

Country

Peptide Process CMC

Not Confirmed

07

Andrew Hendifar

Country

Peptide Process CMC

Not Confirmed

08

Dana-Farber Cancer Institute

U.S.A

Peptide Process CMC

Not Confirmed

09

Abbott Laboratories

U.S.A

Peptide Process CMC

Not Confirmed

10

Children's Hospital of Philadelphia

Country

Peptide Process CMC

Not Confirmed

1
2